Leukemia Cell Mobilization with Plerixafor Plus G-CSF with Busulfan/Fludarabine and Allogeneic Hematopoietic Cell Transplantation in Patients with AML/MDS Is Associated with Decreased Complete Chimerism and GvHD, and Increased Risk of Relapse

被引：1
|
作者：
Benton, Christopher B. [1 ]
Konopleva, Marina
Saliba, Rima M.
Shpall, Elizabeth J.
Ciurea, Stefan O. [2 ]
Kebriaei, Partow [2 ]
Alousi, Amin M. [2 ]
Popat, Uday R. [2 ]
Anderlini, Paolo [2 ]
Nieto, Yago [2 ]
Parmar, Simrit
Zeng, Zhihong [3 ]
Chen, Julianne J.
Rondon, Gabriela [2 ]
McMullin, Becky
Wang, Rui-Yu
Lu, Hongbo [3 ]
Schober, Wendy D. [3 ]
Woodworth, Glenda G.
Gulbis, Alison [4 ]
Cool, Rita [4 ]
Qiao, Wei [5 ]
Thall, Peter F.
Andreeff, Michael
Champlin, Richard E.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Sect Mol Hematol & Therapy, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.360.360
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
360
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Relapse after Allogeneic Hematopoietic Stem Cell Transplantation (HCT) for Acute Myeloid Leukemia (AML)/Myelodysplastic Syndrome (MDS) Following Intravenous Busulfan Plus Fludarabine Based Conditioning: Outcomes and Monocyte Chemo-Attractant Protein-1
    Khaled, Yasser
    Solh, Melhem
    Fondaw, Megan
    Lamontagne, Deborah
    Batista, Anginett
    Chan-Fong, Sauvai
    Sullivan, Joanne
    Matar, Abraham J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S70 - S71
  • [22] 12 Months Report from a Phase 3 Study of Plerixafor plus G-CSF Vs. Placebo plus G-CSF for Mobilization of Hematopoietic Stem Cell for Autologous Transplant in Patients with Multiple Myeloma.
    DiPersio, John F.
    Stadtmauer, Edward A.
    Nademanee, Auayporn P.
    Micallef, Ivana N. M.
    Stiff, Patrick J.
    Bridger, Gary
    Calandra, Gary
    BLOOD, 2008, 112 (11) : 1137 - 1137
  • [23] Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
    Liu, Hui
    Zhai, Xiao
    Song, Zhaoyang
    Sun, Jing
    Xiao, Yang
    Nie, Danian
    Zhang, Yu
    Huang, Fen
    Zhou, Hongsheng
    Fan, Zhiping
    Tu, Sanfang
    Li, Yonghua
    Guo, Xutao
    Yu, Guopan
    Liu, Qifa
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2013, 6
  • [24] Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study
    Hui Liu
    Xiao Zhai
    Zhaoyang Song
    Jing Sun
    Yang Xiao
    Danian Nie
    Yu Zhang
    Fen Huang
    Hongsheng Zhou
    Zhiping Fan
    Sanfang Tu
    Yonghua Li
    Xutao Guo
    Guopan Yu
    Qifa Liu
    Journal of Hematology & Oncology, 6
  • [25] Plerixafor (Mozobil®) Plus G-CSF Is Effective in Mobilizing Hematopoietic Stem Cells in Patients with Concurrent Thrombocytopenia Undergoing Autologous Hematopoietic Stem Cell Transplantation.
    Micallef, Ivana N.
    Jacobsen, Eric
    Shaughnessy, Paul
    Marulkar, Sachin
    Mody, Purvi
    van Rhee, Frits
    BLOOD, 2009, 114 (22) : 1251 - 1251
  • [26] A Phase I/II Trial of Plerixafor/G-CSF Combined With IV Bu/Flu Conditioning Regimen In AML/MDS Patients Undergoing Allogenic Stem Cell Transplantation
    Konopleva, Marina
    Zeng Zhihong
    Wang, Rui-Yu
    Thall, Peter F.
    McCormick, Gloria
    Lu, Hongbo
    Chen, Julianne J.
    Shpall, Elizabeth J.
    Ciurea, Stefan O.
    Kebriaei, Partow
    Alousi, Amin M.
    Popat, Uday
    Anderlini, Paolo
    Nieto, Yago
    Parmar, Simrit
    McMullin, Becky
    Rondon, Gabriela
    Schober, Wendy D.
    Gulbis, Alison
    Cool, Rita
    Lin, E.
    Andreeff, Michael
    Champlin, Richard
    BLOOD, 2010, 116 (21) : 975 - 975
  • [27] Total body irradiation plus fludarabine compared to busulfan plus fludarabine as "reduced-toxicity conditioning" for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT
    Giebel, Sebastian
    Labopin, Myriam
    Sobczyk-Kruszelnicka, Malgorzata
    Stelljes, Matthias
    Byrne, Jenny L.
    Fegueux, Nathalie
    Beelen, Dietrich W.
    Rovira, Montserrat
    Spyridonidis, Alexandros
    Blaise, Didier
    Bornhaeuser, Martin
    Karadogan, Ihsan
    Savani, Bipin N.
    Nagler, Arnon
    Mohty, Mohamad
    Martin, Sonja
    Chevallier, Patrice
    Neubauer, Andreas
    Damaj, Gandhi
    Koc, Yener
    Ganser, Arnold
    Collin, Matthew
    Yakoub-Agha, Ibrahim
    Ozdogu, Hakan
    Araujo, Mercedes Colorado
    Itala-Remes, Maija
    Orchard, Kim
    Isaksson, Cecilia
    Bethge, Wolfgang
    Martin, Hans
    Aljurf, Mahmoud
    Faber, Edgar
    Caballero, Dolores
    Zak, Pavel
    Leleu, Xavier
    Bay, Jacques-Olivier
    Rohrlich, Pierre-Simon
    Kroeger, Nicolaus
    Huynh, Anne
    Schaefer-Eckart, Kerstin
    Milpied, Noel
    Lenhoff, Stig
    Ho, Aloysius
    Lopez, Jose Luis Bello
    Mordini, Nicola
    Lioure, Bruno
    Halaburda, Kazimierz
    Olivieri, Attilio
    Gedde-Dahl, Tobias
    Protheroe, Rachel
    BONE MARROW TRANSPLANTATION, 2021, 56 (02) : 481 - 491
  • [28] EARLY MIXED CHIMERISM DOES NOT ALTER LONG-TERM PROGNOSIS FOR PATIENTS RECEIVING IV BUSULFAN-FLUDARABINE (IV BU-FLU) WITH ALLOGENEIC STEM CELL TRANSPLANTATION FOR AML/MDS
    Tang, X.
    de Lima, M.
    Wei, W.
    Chiattone, A.
    Thall, P. F.
    Medeiros, L. J.
    Rondon, G.
    Shpall, E. J.
    Jones, R. B.
    Nieto, Y.
    Alousi, A.
    Champlin, R. E.
    Andersson, B. S.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S304 - S304
  • [29] Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation
    Dhedin, N.
    Prebet, T.
    De Latour, R. Peffault
    Katsahian, S.
    Kuentz, M.
    Piard, N.
    Rea, D.
    Norol, F.
    Jouet, J. P.
    Ribeil, J. A.
    Tabrizi, R.
    Rio, B.
    Lioure, B.
    Tiberghien, P.
    Bourhis, J. H.
    Sirvent, A.
    Bordigoni, P.
    Blaise, D.
    Michallet, M.
    Vernant, J. P.
    BONE MARROW TRANSPLANTATION, 2012, 47 (12) : 1564 - 1568
  • [30] Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation
    N Dhédin
    T Prébet
    R Peffault De Latour
    S Katsahian
    M Kuentz
    N Piard
    D Réa
    F Norol
    J P Jouet
    J A Ribeil
    R Tabrizi
    B Rio
    B Lioure
    P Tiberghien
    J H Bourhis
    A Sirvent
    P Bordigoni
    D Blaise
    M Michallet
    J P Vernant
    Bone Marrow Transplantation, 2012, 47 : 1564 - 1568
12345